Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches.

Autor: Rzymski P; Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland.; Universal Scientific Education and Research Network (USERN)., Jibril AT; Universal Scientific Education and Research Network (USERN).; Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran., Rahmah L; Universal Scientific Education and Research Network (USERN).; Faculty of Medicine, Universitas Muhammadiyah Surabaya, Surabaya, Indonesia.; Department of Digital Health, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Abarikwu SO; Universal Scientific Education and Research Network (USERN).; Department of Biochemistry, University of Port Harcourt, Choba, PMB, Port Harcourt, Rivers State, Nigeria., Hashem F; Universal Scientific Education and Research Network (USERN).; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Lawati AA; Universal Scientific Education and Research Network (USERN).; Sultan Qaboos University Hospital, Al Khoud, Muscat, Oman., Morrison FMM; Universal Scientific Education and Research Network (USERN).; Akkon University of Human Sciences, Berlin, Germany., Marquez LP; Universal Scientific Education and Research Network (USERN).; University of the Philippines Diliman, Quezon City, Philippines., Mohamed K; Universal Scientific Education and Research Network (USERN).; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Khan A; Universal Scientific Education and Research Network (USERN).; Department of Pharmacy, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.; Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan., Mushtaq S; Universal Scientific Education and Research Network (USERN).; Department of Pharmacy, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China., Minakova K; Universal Scientific Education and Research Network (USERN).; Micro- and Nanoelectronics Department, National Technical University 'Kharkiv Polytechnic Institute', Kharkiv, Ukraine., Poniedziałek B; Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland., Zarębska-Michaluk D; Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland., Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland.

Publikováno v: Journal of medical virology [J Med Virol] 2024 Sep; Vol. 96 (9), pp. e29900.

P0674 : Clinically approved T-type calcium channel inhibitors prevent hepatitis C virus (HCV) membrane fusion in a genotype-dependent manner

Autor: Perin, P.M., Haid, S., Brown, R., Schulze, K., Colpitts, C.C., Zeilinger, C., von Schaewen, M., Heller, B., Vercauteren, K., Luxenburger, E., Andonyadis, Y., Vondran, F., Kirschning, A., Schang, L.M., Müller, R., Guzman, C.A., Kaderali, L., Randall, G., Meuleman, P., Ploss, A., Pietschmann, T.

Publikováno v: In Journal of Hepatology April 2015 62 Supplement 2:S574-S575

Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.

Autor: Ding Q; Princeton University, Department of Molecular Biology, Lewis Thomas Laboratory, Princeton New Jersey, USA., von Schaewen M; Princeton University, Department of Molecular Biology, Lewis Thomas Laboratory, Princeton New Jersey, USA., Hrebikova G; Princeton University, Department of Molecular Biology, Lewis Thomas Laboratory, Princeton New Jersey, USA., Heller B; Princeton University, Department of Molecular Biology, Lewis Thomas Laboratory, Princeton New Jersey, USA., Sandmann L; Hannover Medical School, Hannover, Germany., Plaas M; University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Laboratory Animal Centre, Tartu, Estonia., Ploss A; Princeton University, Department of Molecular Biology, Lewis Thomas Laboratory, Princeton New Jersey, USA aploss@princeton.edu.

Publikováno v: Journal of virology [J Virol] 2017 Jan 31; Vol. 91 (4). Date of Electronic Publication: 2017 Jan 31 (Print Publication: 2017).

Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.

Autor: Li D; Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China., von Schaewen M; Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA., Wang X; Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China., Tao W; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China., Zhang Y; Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China., Li L; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China., Heller B; Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA., Hrebikova G; Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA., Deng Q; Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China., Ploss A; Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA., Zhong J; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China huangzhong@ips.ac.cn jzhong@sibs.ac.cn., Huang Z; Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China huangzhong@ips.ac.cn jzhong@sibs.ac.cn.

Publikováno v: Journal of virology [J Virol] 2016 Nov 14; Vol. 90 (23), pp. 10486-10498. Date of Electronic Publication: 2016 Nov 14 (Print Publication: 2016).

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.

Autor: Perin PM; Institute of Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover and the Helmholtz Centre for Infection Research, Hannover, Germany., Haid S; Institute of Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover and the Helmholtz Centre for Infection Research, Hannover, Germany., Brown RJ; Institute of Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover and the Helmholtz Centre for Infection Research, Hannover, Germany., Doerrbecker J; Institute of Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover and the Helmholtz Centre for Infection Research, Hannover, Germany., Schulze K; Department of Vaccinology and Applied Microbiology, Helmholtz Centre of Infection Research, Braunschweig, Germany., Zeilinger C; Institute of Organic Chemistry and Center of Biomolecular Drug Research, Leibniz Universität, Hannover, Germany., von Schaewen M; Department of Molecular Biology, Princeton University, Princeton, NJ., Heller B; Department of Molecular Biology, Princeton University, Princeton, NJ., Vercauteren K; Center for Vaccinology, Ghent University, Ghent, Belgium., Luxenburger E; Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany., Baktash YM; Department of Microbiology, The University of Chicago, Chicago, IL., Vondran FW; ReMediES, Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany.; German Centre for Infection Research, Hannover-Braunschweig, Germany., Speerstra S; Department of Biochemistry, University of Alberta, Edmonton, AB, Canada.; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada., Awadh A; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada., Mukhtarov F; Department of Biochemistry, University of Alberta, Edmonton, AB, Canada.; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada., Schang LM; Department of Biochemistry, University of Alberta, Edmonton, AB, Canada.; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada., Kirschning A; Institute of Organic Chemistry and Center of Biomolecular Drug Research, Leibniz Universität, Hannover, Germany., Müller R; Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany., Guzman CA; Department of Vaccinology and Applied Microbiology, Helmholtz Centre of Infection Research, Braunschweig, Germany., Kaderali L; Technical University Dresden, Dresden, Germany., Randall G; Department of Microbiology, The University of Chicago, Chicago, IL., Meuleman P; Center for Vaccinology, Ghent University, Ghent, Belgium., Ploss A; Department of Molecular Biology, Princeton University, Princeton, NJ., Pietschmann T; Institute of Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover and the Helmholtz Centre for Infection Research, Hannover, Germany.; German Centre for Infection Research, Hannover-Braunschweig, Germany.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2016 Jan; Vol. 63 (1), pp. 49-62. Date of Electronic Publication: 2015 Oct 09.